An elevated C-reactive protein level in an inpatient rehabilitation setting after joint replacement: To act or not to act? - that is the question.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
26 Feb 2021
Historique:
received: 30 05 2020
accepted: 14 01 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 17 3 2021
Statut: ppublish

Résumé

C-reactive protein (CRP) is part of a battery of "routine bloods" performed by residents on patients when they are admitted into a rehabilitation unit. Generally, an elevated CRP is considered to be an indicator of an acute infective process. Numerous studies have indicated that the CRP peaks on the 2nd or 3rd day post total hip arthroplasty (THR) and total knee arthroplasty (TKR) and returns to normal by day 7. When the CRP level remains elevated, it is generally felt that infection should be excluded.We performed a prospective study on 45 consecutive patients admitted into a rehabilitation unit post hip and knee arthroplasty over a 6 months period, to evaluate the incidence of an elevated CRP on admission, to determine whether an isolated elevated CRP on admission to a rehabilitation setting should not be considered as an indicator of an infective process.We found all patients (100%) had elevated CRP's on admission, ranging from 8.6 mg/L to 139.2 mg/L, between days 5-7 post-operatively. By day 14, CRP's reduced, but 91% of patients still had elevated CRP's, ranging from 2.1 mg/L to 47.3 mg/L after THR and 4.8 mg/L to 40 mg/L after TKR at day 14.These results suggest that even in uncomplicated elective joint arthroplasty, CRP's can remain elevated up to 14 days post-procedure, in the absence of an infective process.An isolated elevated CRP on admission to a rehabilitation setting should not be considered as an indicator of an infective process, but rather part of the normal post-operative inflammatory response. The elevated CRP should be monitored and only an upward trend requires further investigation and management.

Identifiants

pubmed: 33663068
doi: 10.1097/MD.0000000000024584
pii: 00005792-202102260-00031
pmc: PMC7909121
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e24584

Informations de copyright

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose

Références

Park KK, Kim TK, Chang CB, et al. Normative temporal values of CRP and ESR in unilateral and staged bilateral TKA. Clin Orthop Relat Res 2008;466:179–88.
Costa L, Soares D, Aido R, et al. The value of monitoring inflammatory markers after total joint arthroplasty. Hard Tissue 2013;2:17.
Elsevier Saunders, Kumar V, Abbas AK, Nelson F, et al. Robbins and Cotran Pathologic Basis of Disease. 8th ed.2010;74,75,498.
Gabay C, Kushner I. Acute-Phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.
McPherson RA, Matthew R, Pincus MR. Henry's clinical diagnosis and management by laboratory methods. 22nd ed.2011;Philadelphia;: Elsevier Saunders, 254-255, 96, 269,270, 521.
Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972.
Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009;20:182–9.
Enocsson H, Sjöwall C, Skogh T, et al. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum 2009;60:3755.
Laiho K, Mäenpää H, Kautiainen H, et al. Rise in serum C-reactive protein after hip and knee arthroplasties in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:275–7.
Burtis CA, Ash wood ER, Burns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed.2008;St. Louis: Elsevier Saunders, 301.
White J, Kelly M, Dunsmuir R. C-reactive protein level after total hip and total knee replacement. J Bone Joint Surg 1998;80-B:909.
Dupont C, Rodenbach J, Flachaire E. The value of C - reactive protein for post-operative monitoring of lower limb arthroplasty. Ann Readapt Med Phys 2008;51:348–57.
Neumaier M, Metak G, Scherer MA. C - reactive protein as a parameter of surgical trauma: CRP response after different types of surgery in 349 hip fractures. Acta Orthop 2006;77:788–90.
Niskanen RO1, Korkala O, Pammo H. Serum C-reactive protein levels after total hip and knee arthroplasty. J Bone Joint Surg Br 1996;78:431–3.
Bogaty P, Brophy JM, Boyer L, et al. Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med 2005;165:221–6.
Elgeidi A, Elganainy AE, Abou Elkhier N, et al. Interleukin-6 and other inflammatory markers in the diagnosis of peri-prosthetic joint infection. Int Orthop 2014;38:2591–5.

Auteurs

Arun Aggarwal (A)

Neurologist and Rehabilitation / Pain Physician, Metropolitan Rehabilitation Hospital & Hunters Hill Private Hospital.

Vikram Sinha (V)

Rehabilitation Medicine Registrar, Metropolitan Rehabilitation Hospital.

Eric Chan (E)

General Practice Registrar, Hunters Hill Private Hospital.

Anuka Parapuram (A)

Rehabilitation Medicine Physician, Metropolitan Rehabilitation Hospital, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH